Relation of Hyperemic Epicardial Flow to Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy
To access this article, please choose from the options below
This study was supported in part by a grant from Sanofi-Aventis, Paris, France, and Bristol-Myers Squibb, Princeton, New Jersey.
PII: S0002-9149(08)00047-7
doi:10.1016/j.amjcard.2007.12.023
© 2008 Elsevier Inc. All rights reserved.
